Predict your next investment

HEALTHCARE | Biotechnology
vitatex.com

See what CB Insights has to offer

Competitors

16

Business Relationships

1

Vitatex Competitors & Alternatives

16 Competitors

Vitatex has 16 competitors. Vitatex's competitors are Acumen Pharmaceuticals, Noveome Biotherapeutics, LeadScope, Dyax, Vermillion and more.

Latest Funding

Companies

Investment Stage

Total Funding

Mosaic
The Mosaic Score is an algorithm that measures the overall financial health and market potential of private companies.

Location

7/1/2021

IPO

$2.2M

Virginia

10/2/2020

Unattributed

$23.78M

Pennsylvania

4/30/2020

Loan

$7.25M

Ohio

1/22/2016

Acq - P2P

$48.8M

Massachusetts

5/20/2015

PIPE - II

$53.35M

California

4/30/2013

ERYtech Pharma

IPO

$26.2M

France

9/8/2010

Pevion Biotech

Unattributed VC

$9.89M

Switzerland

2/5/2010

Arcxis Biotechnologies

Series C - II

$8.5M

California

10/13/2008

CELLective Dx Corporation

Unattributed VC - II

$24.72M

California

Emiliem

Michigan

Latest Funding

7/1/2021

10/2/2020

4/30/2020

1/22/2016

5/20/2015

4/30/2013

9/8/2010

2/5/2010

10/13/2008

Companies

ERYtech Pharma

Pevion Biotech

Arcxis Biotechnologies

CELLective Dx Corporation

Emiliem

Investment Stage

IPO

Unattributed

Loan

Acq - P2P

PIPE - II

IPO

Unattributed VC

Series C - II

Unattributed VC - II

Total Funding

$2.2M

$23.78M

$7.25M

$48.8M

$53.35M

$26.2M

$9.89M

$8.5M

$24.72M

Mosaic

Location

Virginia

Pennsylvania

Ohio

Massachusetts

California

France

Switzerland

California

California

Michigan

Vitatex Partners & Customers

1 Partners and customers

Vitatex has 1 strategic partners and customers. Vitatex recently partnered with Noble Life Sciences on December 12, 2013.

Date

Type

Business Partner

Country

News Snippet

Sources

12/5/2013

Licensee

Noble Life Sciences

United States

Posted by Che Chen on. Vitatex Licenses CAM CTC Technology to Noble Life Sciences for Metasta Home › News ›Vitatex Licenses CAM CTC Technology to Noble Life Sciences for Metastasis Drug Development Services.

Vitatex announced that it has licensed its patented Cell Adhesion Matrix-Based Enrichment technology for the isolation of viable metastasis-initiating invasive circulating tumor cells to Noble Life Sciences .

1

Date

12/5/2013

Type

Licensee

Business Partner

Noble Life Sciences

Country

United States

News Snippet

Posted by Che Chen on. Vitatex Licenses CAM CTC Technology to Noble Life Sciences for Metasta Home › News ›Vitatex Licenses CAM CTC Technology to Noble Life Sciences for Metastasis Drug Development Services.

Vitatex announced that it has licensed its patented Cell Adhesion Matrix-Based Enrichment technology for the isolation of viable metastasis-initiating invasive circulating tumor cells to Noble Life Sciences .

Sources

1

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.